126エピソード

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

PeerVoice Oncology & Haematology Video PeerVoice

    • 科学

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

    • video
    Evolving Treatment Paradigm in Early-Stage EGFR-Mutant NSCLC: A Primer for Medical Oncologists

    Evolving Treatment Paradigm in Early-Stage EGFR-Mutant NSCLC: A Primer for Medical Oncologists

    Visit https://www.peervoice.com/ESR860 to view the entire programme with slides. After completing “Evolving Treatment Paradigm in Early-Stage EGFR-Mutant NSCLC: A Primer for Medical Oncologists”, participants will be able to: Discuss recent clinical data on the management of early-stage EGFR-mutant NSCLC; Explain best practices for mutational testing in patients with early-stage EGFR-mutant NSCLC; Develop strategies to improve communication and collaboration among the multidisciplinary team.

    • 16分
    • video
    Best Practices in Early-Stage EGFR-Mutant NSCLC: A Primer for Radiation Oncologists

    Best Practices in Early-Stage EGFR-Mutant NSCLC: A Primer for Radiation Oncologists

    Visit https://www.peervoice.com/CHA860 to view the entire programme with slides. After completing “Best Practices in Early-Stage EGFR-Mutant NSCLC: A Primer for Radiation Oncologists”, participants will be able to: Discuss recent clinical data on the management of early-stage EGFR-mutant NSCLC; Explain best practices for mutational testing in patients with early-stage EGFR-mutant NSCLC; Develop strategies to improve communication and collaboration among the multidisciplinary team.

    • 19分
    • video
    Improving Outcomes in Localised EGFR-Mutant NSCLC: Perspectives for Pulmonologists

    Improving Outcomes in Localised EGFR-Mutant NSCLC: Perspectives for Pulmonologists

    Visit https://www.peervoice.com/VDG860 to view the entire programme with slides. After completing “Improving Outcomes in Localised EGFR-Mutant NSCLC: Perspectives for Pulmonologists”, participants will be able to: Discuss recent clinical data on the management of localised EGFR-mutant NSCLC; Explain best practices for mutational testing in patients with localised EGFR-mutant NSCLC; Develop strategies to improve communication and collaboration among the multidisciplinary team.

    • 26分
    • video
    Could PSMA Be the ‘Bulls-Eye’ Target in mCRPC?

    Could PSMA Be the ‘Bulls-Eye’ Target in mCRPC?

    Visit https://www.peervoice.com/GPC860 to view the entire programme with slides. After completing “Could PSMA Be the ‘Bulls-Eye’ Target in mCRPC?”, participants will be able to: Describe the mechanism of the prostate-specific membrane antigen (PSMA) theranostic approach in metastatic castration-resistant prostate cancer (mCRPC); Recall the clinical trials for the development of PSMA radioligand therapy in mCRPC; Identify which patients may be considered candidates for 177Lu-PSMA-617 therapy.

    • 19分
    • video
    Is It the Carrot or the Stick? Practical Strategies for Improving Adherence to Antidiabetic Therapy

    Is It the Carrot or the Stick? Practical Strategies for Improving Adherence to Antidiabetic Therapy

    Visit https://www.peervoice.com/NMW860 to view the entire programme with slides. After completing “Is It the Carrot or the Stick? Practical Strategies for Improving Adherence to Antidiabetic Therapy”, participants will be able to: Describe the cardiovascular adverse events that have been associated with use of proteasome inhibitors for treatment of multiple myeloma; Develop strategies to prevent and manage cardiovascular adverse events in patients with multiple myeloma.

    • 28分
    • video
    Addressing Challenges in Lung Cancer Patient Management From Diagnosis to Treatment in a Community Setting

    Addressing Challenges in Lung Cancer Patient Management From Diagnosis to Treatment in a Community Setting

    Visit https://www.peervoice.com/RWV860 to view the entire programme with slides. After completing “Addressing Challenges in Lung Cancer Patient Management From Diagnosis to Treatment in a Community Setting”, participants will be able to: Identify best practices to facilitate the patient journey in non–small-cell lung carcinoma (NSCLC) from diagnosis to treatment.

    • 14分

科学のトップPodcast

他のリスナーはこちらのサブスクリプションにも登録しています

PeerVoiceのその他の作品